nach oben

Current Sexual Health Reports

Erschienen in:

29.10.2018 | Female Sexual Dysfunction and Disorders (T Lorenz and R Nappi, Section Editors)

Sexual Desire in Women According to Reproductive Milestones

verfasst von: Erika L. Kelley

Erschienen in: Current Sexual Health Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This was a selective review of the recent (i.e., past 5 years) literature on female sexual desire according to reproductive milestones (adolescence, puerperium, and menopause), framed within a biopsychosocial model.

Recent Findings

Scant recent research has focused on adolescence, though evidence suggests cognitive capacities for motivation for sexual behavior similar to adults. Research on the puerperium provides further evidence of temporary declines in desire and tested differences according to characteristics of delivery. Most recent research has focused on menopause including identification of biological mechanisms behind desire and demonstration of short-term efficacy of hormonal therapies for decreased desire.

Summary

Conclusions about desire according to reproductive milestones continue to be limited by variations in methodology and sample characteristics. Future studies using preclinical animal models, novel imaging techniques, and genetics-based studies to better understand the biologic underpinnings of inhibitory and excitatory processes driving (low) sexual desire are warranted. Studies should also further consider psychosocial variables (e.g., sexual fluidity, partner’s desire, and perceptions of role transitions) in understanding (low) desire during these milestones.

American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin no. 119: Female sexual dysfunction. Obstet Gynecol. 117:996–1007. doi: https://doi.org/10.1097/AOG.0b013e31821921ce.

Hayes RD, Dennerstein L, Bennett CM, Koochaki PE, Leiblum SR, Graziottin A. Relationship between hypoactive sexual desire disorder and aging. Fertil Steril. 2007;87(1):107–12. https://doi.org/10.1016/j.fertnstert.2006.05.071.CrossRefPubMed

• Kingsberg SA, Clayton AH, Pfaus JG. The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder. CNS Drugs. 2015;29:915–33. https://doi.org/10.1007/s40263-015-0288-1 Overview of biopscychosocial model and biological underpinnings of female sexual response. CrossRefPubMed

Nappi RE, Cucinella L, Martella S, Rossi M, Tiranini L, Martini E. Female sexual dysfunction (FSD): prevalence and impact on quality of life (QoL). Maturitas. 2016;94:87–91. https://doi.org/10.1016/j.maturitas.2016.09.013.CrossRefPubMed

Moreau C, Kagesten AE, Blum RW. Sexual dysfunction among youth: an overlooked sexual health concern. BMC Public Health. 2016;16:1170. https://doi.org/10.1186/s12889-016-3835-x.CrossRefPubMedPubMedCentral

Olsson M, Steineck G, Enskar K. Sexual function in adolescent and young adult cancer survivors—a population-based study. J Cancer Surviv. 2018;12:450–9. https://doi.org/10.1007/s11764-018-0684-x.CrossRefPubMed

Chang SR, Chen KH, Ho HN, Lai YH, Lin MI, Lee CN, et al. Depressive symptoms, pain, and sexual dysfunction over the first year following vaginal or cesarean delivery: a prospective longitudinal study. Int J Nurs Stud. 2015;52:1433–44. https://doi.org/10.1016/j.ijnurstu.2015.04.019.CrossRefPubMed

Faisal-Cury A, Menezes PR, Quayle J, Matijasevich A, Diniz SG. The relationship between mode of delivery and sexual health outcomes after childbirth. J Sex Med. 2015;12:1212–20. https://doi.org/10.1111/jsm.12883.CrossRefPubMed

Islam RM, Bell RJ, Davis SR. Prevalence of sexual symptoms in relation to menopause in women in Asia: a systematic review. Menopause. 2018;25:231–8. https://doi.org/10.1097/GME.0000000000000967. CrossRefPubMed

10.

Hashemi S, Tehrani FR, Simbar M, Abedini M, Behreinian H. Evaluation of sexual attitude and sexual function in menopausal age; a population based cross-sectional study. Iran J Reprod Med. 2013;11(8):631–6.PubMedPubMedCentral

11.

Worsley R, Bell RJ, Gartoulla P, Davis SR. Prevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife women. J Sex Med. 2017;14:675–86. https://doi.org/10.1016/j.jsxm.2017.03.254.CrossRefPubMed

12.

Quinn-Nilas C, Milhausen RR, McKay A, Holzapfel S. Prevalence and predictors of sexual problems among midlife Canadian adults: results from a national survey. J Sex Med. 2018;15:873–9. https://doi.org/10.1016/j.jsxm.2018.03.086.CrossRefPubMed

13.

Wong EL, Huang F, Cheung AWL, Wong CKM. The impact of menopause on the sexual health of Chinese Cantonese women: a mixed methods study. J Adv Nurs. 2018;74:1672–84. https://doi.org/10.1111/jan.13568.CrossRefPubMed

14.

Kastbom AA, Sydsjo G, Bladh M. Differences in sexual behavior, health, and history of child abuse among school students who had not engaged in sexual activity by the age of 18 years: a cross-sectional study. Adolesc Health Med Ther. 2016;7:1–11. https://doi.org/10.2147/AHMT.S95493. CrossRefPubMedPubMedCentral

15.

Hensel DJ, Selby S, Tanner AE, Fortenberry JD. A daily diary analysis of condom breakage and slippage during vaginal sex or anal sex among adolescent women. Sex Transm Dis. 2016;43:531–6. https://doi.org/10.1097/OLQ.0000000000000487.CrossRefPubMedPubMedCentral

16.

Ballonoff Suleiman A, Johnson M, Shirtcliff EA. School-based sex education and neuroscience: what we know about love, romance, marriage, and adolescent brain development. J Sch Health. 2015;85(8):567–74. https://doi.org/10.1111/josh.12285.CrossRefPubMed

17.

Fortenberry JD. Puberty and adolescent sexuality. Horm Behav. 2013;64(2):280–7. https://doi.org/10.1016/j.yhbeh.2013.03.007.CrossRefPubMedPubMedCentral

18.

Diamond LM. Female bisexuality from adolescence to adulthood: results from a 10-year longitudinal study. Dev Psychol. 2008;44:5–14. https://doi.org/10.1037/0012-1649.44.1.5.CrossRefPubMed

19.

Asselmann E, Hoyer J, Wittchen HU, Martini J. Sexual problems during pregnancy and after delivery among women with and without anxiety and depressive disorders prior to pregnancy: a prospective-longitudinal study. J Sex Med. 2016;13:95–104. https://doi.org/10.1016/j.jsxm.2015.12.005.CrossRefPubMed

20.

Khajehei M, Doherty M, Tilley M, Sauer K. Prevalence and risk factors of sexual dysfunction in postpartum Australian women. J Sex Med. 2015;12:1415–26. https://doi.org/10.1111/jsm.12901.CrossRefPubMed

21.

Jawed-Wessel S, Schick V, Herbenick D. The Sexual Function Questionnaire’s Medical Impact Scale (SFQ-MIS): validation among a sample of first-time mothers. J Sex Med. 2013;10:2715–22. https://doi.org/10.1111/jsm.12307.CrossRefPubMed

22.

Syrjala K, Shroeder T, Abrams J, Atkins T, Brown W, Sanders J, et al. Sexual function measurement and outcomes in cancer survivors and matched controls. J Sex Res. 2000;37:213–25. https://doi.org/10.1080/00224490009552042.CrossRef

23.

Dogan B, Gun I, Ozdamar O, Yilmaz A, Muhcu M. Long-term impacts of vaginal birth with mediolateral episiotomy on sexual and pelvic dysfunction and perineal pain. J Matern Fetal Neonatal Med. 2017;30:457–60. https://doi.org/10.1080/14767058.2016.1174998.CrossRefPubMed

24.

Kaya B, Usluogullari B, Yurttutan N, Sahan MG, Guralp O, Malik E. Does ligation of internal iliac artery for postpartum hemorrhage affect clitoral artery blood flow and postpartum sexual function? Eur J Obstet Gynecol Reprod Biol. 2017;219:124–8. https://doi.org/10.1016/j.ejogrb.2017.10.029. CrossRefPubMed

25.

O’Malley D, Higgins A, Smith V. Postpartum sexual health: a principle-based concept analysis. J Adv Nurs. 2015;71(10):2247–57. https://doi.org/10.1111/jan. CrossRefPubMed

26.

Spector IP, Carey MO, Steinberg L. The sexual desire inventory: development, factor structure, and evidence of reliability. J Sex Marital Ther. 1996;22:175–90. https://doi.org/10.1080/00926239608414655.CrossRefPubMed

27.

Rosen NO, Bailey K, Muise A. Degree and direction of sexual desire discrepancy are linked to sexual and relationship satisfaction in couples transitioning to parenthood. J Sex Res. 2018;55:214–25. https://doi.org/10.1080/00224499.2017.1321732.CrossRefPubMed

28.

Rosen NO, Mooney K, Muise A. Dyadic empathy predicts sexual and relationship well-being in couples transitioning to parenthood. J Sex Marital Ther. 2018;43:543–59. https://doi.org/10.1080/0092623X.2016.1208698.CrossRef

29.

Cappell J, MacDonald TK, Pukall CF. For new mothers, the relationship matters: relationship characteristics and postpartum sexuality. Can J Hum Sex. 2016;25(2):126–37. https://doi.org/10.3138/cjhs.252-A5.CrossRef

30.

Gregory R, Cheng H, Rupp HA, Sengelaub DR, Heiman JR. Oxytocin increases VTA activation to infant and sexual stimuli in nulliparous and postpartum women. Horm Behav. 2015;69:82–8. https://doi.org/10.1016/j.yhbeh.2014.12.009.CrossRefPubMedPubMedCentral

31.

Achilli C, Pundir J, Ramanathan P, Sabatini L, Hamoda H, Panay N. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. Fertil Steril. 2017;107:475–82. https://doi.org/10.1016/j.fertnstert.2016.10.028.CrossRefPubMed

32.

Cappelletti M, Wallen K. Increasing women’s sexual desire: the comparative effectiveness of estrogens and androgens. Horm Behav. 2016;78:178–93. https://doi.org/10.1016/j.yhbeh.2015.11.003.CrossRefPubMed

33.

Ganesan K, Habboush Y, Sultan S. Transdermal testosterone in female hypoactive sexual desire disorder: a rapid qualitative systematic review using grading of recommendations assessment development and evaluation. Cureus. 2018;10(3):e2401. https://doi.org/10.7759/cureus.2401.CrossRefPubMedPubMedCentral

34.

Thornton K, Chervenak J, Neal-Perry G. Menopause and sexuality. Endocrinol Metab Clin N Am. 2015;44(3):649–61. https://doi.org/10.1016/j.ecl.2015.05.009.CrossRef

35.

• Jones SL, Ismail N, Pfaus JG. Facilitation of sexual behavior in ovariectomized rats by estradiol and testosterone: a preclinical model of androgen effects on female sexual desire. Psychoneuroendocrinology. 2017;79:122–33. https://doi.org/10.1016/j.psyneuen.2017.02.018 novel animal study useful for developing preclinical model. CrossRefPubMed

36.

• Wahlin-Jacobsen S, Pederson AT, Kristensen E. Is there a correlation between androgens and sexual desire in women? J Sex Med. 2015;12:358–73. https://doi.org/10.1111/jsm.12774 examined use of novel measure of circulating androgens. CrossRefPubMed

37.

Randolph JF, Zheng H, Avis NE, Greendale GA, Harlow SD. Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition. J Clin Endocrinol Metab. 2015;100(1):258–66. https://doi.org/10.1210/jc.2014-1725.CrossRefPubMed

38.

Kokcu A, Kurtoglu E, Bildircin D, Celik H, Kaya A, Alper T. Does surgical menopause affect sexual performance differently from natural menopause? J Sex Med. 2015;12:1407–14. https://doi.org/10.1111/jsm.12891.CrossRefPubMed

39.

Tucker PE, Bulsara MK, Salfinger SG, Tan JJS, Green H, Cohen PA. Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy. Gynecol Oncol. 2016;140:95–100. https://doi.org/10.1016/j.ygyno.2015.11.002.CrossRefPubMed

40.

Simon JA, Goldsten I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, et al. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women’s Sexual Health (ISSWSH) expert consensus panel review. Menopause. 2018;25:837–47. https://doi.org/10.1097/GME.0000000000001138.CrossRefPubMed

41.

Osborne V, Layton D, Shakir SAW. Implications of off-label use: an example from the final results of an observational cohort study on Intrinsa (testosterone patch). Post Reproductive Health. 2014;20(2):48–54. https://doi.org/10.1177/2053369114535762.CrossRefPubMed

42.

Davis SR, Worsley R, Miller KK, Parish SJ, Santoro N. Androgens and female sexual function and dysfunction—findings from the fourth International Consultation of Sexual Medicine. J Sex Med. 2016;13:168–78. https://doi.org/10.1016/j.jsxm.2015.12.033.CrossRefPubMed

43.

Labrie F, Derogatis L, Archer DF, Koltun W, Vachon A, Young D, et al. Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy. J Sex Med. 2015;12:2401–12. https://doi.org/10.1111/jsm.13045.CrossRefPubMed

44.

Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M, Sand M. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause. 2013;21(6):633–40. https://doi.org/10.1097/gme.0000000000000134.CrossRef

45.

Portman DJ, Brown L, Yuan J, Kissling R, Kingsberg SA. Flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the PLUMERIA study. J Sex Med. 2017;14:834–42. https://doi.org/10.1016/j.jsxm.2017.03.258.CrossRefPubMed

46.

Pellow J, McGrath L. Herbal medicine for low sexual desire in menopausal women: a clinical review. Complement Ther Clinc Pract. 2016;25:122–9. https://doi.org/10.1016/j.ctcp.2016.09.007.CrossRef

47.

Choi SY, Kang P, Lee HS, Sol GH. Effects of inhalation of essential oil of citrus aurantium L. var amara on menopausal symptoms, stress, and estrogen in postmenopausal women: a randomized controlled trial. J Evid Based Complementary Altern Med. 2014;2:1–7. https://doi.org/10.1155/2014/796518.CrossRef

48.

Pebdani MA, Taavoni S, Seyedfatemi N, Haghani H. Triple-blind, placebo-controlled trial of Ginkgo biloba extract on sexual desire in postmenopausal women in Tehran. Iran J Nurs Midwifery Res. 2014;19:262–5.PubMedPubMedCentral

49.

Postigo S, Lima SMRR, Tamada SS, dos Resi BF, Dutra da Silva GM, Aoki T. Assessment of the effects of Tribulus terrestris on sexual function of menopausal women. Rev Bras Ginecol Obstet. 2016;38:140–6. https://doi.org/10.1055/s-0036-1571472.CrossRefPubMed

50.

Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS). Menopause. 2006;13(1):46–56. https://doi.org/10.1097/01.gme.0000172596.76272.06.CrossRefPubMed

51.

The NAMS. 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728–53. https://doi.org/10.1097/GME.0000000000000921.CrossRef

52.

Portman DJ, Gass MLS. The Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society. J Sex Med. 2014;11:2865–72. https://doi.org/10.1097/GME.0000000000000329. CrossRefPubMed

Titel: Sexual Desire in Women According to Reproductive Milestones
verfasst von: Erika L. Kelley
Publikationsdatum: 29.10.2018
Verlag: Springer US
Erschienen in: Current Sexual Health Reports / Ausgabe 4/2018
Print ISSN: 1548-3584
Elektronische ISSN: 1548-3592
DOI: https://doi.org/10.1007/s11930-018-0184-z

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Contemporary Review of BPH Medical and Surgical Treatments on Sexual Function

A Review of Recent Innovations in the Treatment of Low Sexual Desire

Vocal Signals of Sexual Motivation in Male and Female Rodents

Spermatic Cord Denervation for Chronic Orchialgia